Please provide your email address to receive an email when new articles are posted on . In a video exclusive, Marlyn Mayo, MD, of the University of Texas Southwestern Medical Center, reported ...
Please provide your email address to receive an email when new articles are posted on . More than half of patients with primary biliary cholangitis who received elafibranor 80 mg achieved a ...
CNP-104 improved key cholestasis endpoints at one year, including a composite serum alkaline phosphatase (ALP) and bilirubin biochemical response Durable effects observed across liver stiffness, ...
(RTTNews) - Primary Biliary Cholangitis is a rare, progressive, chronic autoimmune disease of the liver in which the small bile ducts are gradually destroyed, causing bile and other toxins to build up ...
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disorder that most commonly affects middle-aged men. PSC is strongly associated with IBD, and in this setting the risk of colorectal ...
The diagnostic value of primary biliary cholangitis (PBC)-specific antibodies in patients with elevated alkaline phosphatase (ALP) and gamma-glutamyl transferase (GGT) levels, and other identifiable ...
Cholestasis is a liver disease. It occurs when the flow of bile from your liver is reduced or blocked. Bile is fluid produced by your liver that aids in the digestion of food, especially fats. When ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that the first patient has been enrolled in Mirum’s Phase 2b VISTAS study evaluating volixibat in adult ...
Ipsen SA (OTC: IPSEY) and Genfit SA (NASDAQ: GNFT) announced topline data from the Phase 3 ELATIVE trial evaluating the efficacy and safety of elafibranor for primary biliary cholangitis (PBC) who ...
Background Following a motorcycle accident, a 30-year-old male with multiple traumas—including liver rupture, traumatic fractures, cerebral hemorrhage, hepatic hematoma and respiratory failure—was ...
Cholestasis is a Greek word that means stopping or slowing of bile flow from the liver to the small intestine due to a block (obstruction) in the biliary duct system that connects the liver and small ...
Ipsen’s Iqirvo (elafibranor) has been recommended by the National Institute for Health and Care Excellence (NICE) to treat adults with the rare liver disease primary biliary cholangitis (PBC). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results